Shukra Pharmaceuticals Ltd. ASM(additional surveillance measure) as of Aug 14, 2022

Latest status

Short Term ASM - BSE, Stage I

History
Exchange Long/Short Term Stage Entry date Exit date
BSE Short Term Stage I 02 Aug 2022 Active
BSE Short Term Stage II 11 Jul 2022 02 Aug 2022
BSE Short Term Stage I 09 Jun 2022 11 Jul 2022
BSE Long Term Stage II 27 Apr 2021 07 May 2021
BSE Long Term Stage I 16 Apr 2021 27 Apr 2021
BSE Short Term Stage I 15 Dec 2020 23 Dec 2020
BSE Long Term Stage I 07 Aug 2020 28 Aug 2020
BSE Short Term Stage I 10 Oct 2019 13 Nov 2019

1. What is ASM (Additional Surveillance Measure)?

The main objective of ASM is 

More details about ASM can be found on the following links:

2. Should shortlisting under ASM be construed as an adverse action against the concerned company/entity?

The shortlisting of securities under ASM is purely on account of market surveillance and it should not be construed as an adverse action against the concerned company/ entity.

3. What are the criteria for shortlisting scrips under ASM framework?

The shortlisting of securities for placing in ASM framework is based on an objective criteria as jointly decided by SEBI and Exchanges covering the following market based dynamic parameters: